India R&D Funding Gap: Government Dominates, Startup Commercialization Lags

ECONOMY
Whalesbook Logo
AuthorRiya Kapoor|Published at:
India R&D Funding Gap: Government Dominates, Startup Commercialization Lags
Overview

Union Minister Dharmendra Pradhan called for a 50-50 government-industry R&D funding split, citing India's 70% government contribution as unhealthy. Despite a ₹1 lakh crore RDI corpus and a surge to over 2.5 lakh startups, the nation faces a significant "valley of death" in commercializing research. With R&D spending at only 0.64% of GDP and low private sector involvement (36%), translating innovation into market-ready products remains a critical challenge, impacting India's global competitiveness despite its rising Global Innovation Index rank.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Funding Imbalance: Government Dominates R&D Spend

Union Minister Dharmendra Pradhan highlighted a critical issue: India's R&D funding is heavily reliant on the government, making up an estimated 70%. He called this "not a healthy sign," noting it differs greatly from innovation leaders like China (77% private), the U.S. (75% private), and South Korea (79% private). India's total R&D spending stands at just 0.64% of GDP, far below the 2.5%-5% seen in leading nations. Although the government has set aside a ₹1 lakh crore corpus to encourage private investment, the private sector's direct contribution to R&D remains low at around 36%. This public funding reliance can steer resources towards less risky, incremental projects, potentially stifling breakthrough innovations needed for global competition.

Startup Boom Meets Reality: The 'Valley of Death'

India's innovation story often features its rapidly expanding startup scene, now over 2.5 lakh ventures strong, and its climb to 38th place in the Global Innovation Index. However, these numbers mask a tough reality: the ecosystem faces high failure rates. About 90% of startups collapse within five years, with over 11,000 shutting down in 2025 alone. The critical "valley of death"—the gap between early research and market launch—remains a major obstacle, as many startup patents are just concepts rather than ready-to-sell products. A cash crunch, worsened by a difficult funding environment in 2025, has increased early-stage failures. The focus on rapid growth over profits proved unsustainable for many, leading to a market correction favoring economic viability.

IIT Madras: A Model for Industry-Academia Links

Institutions like IIT Madras are showing ways to connect academic research with industrial application. Through its Research Park and Incubation Cell, IIT Madras supports startups and helps transfer technology. Initiatives such as the Healthcare Technology Innovation Centre (HTIC), which has launched 12 successful medical devices, and collaborations with companies like Caterpillar Inc., offer examples of effective industry-academia partnerships. The institute's drive for market-relevant innovation and global reach through its Research Foundation aims to speed up commercialization. While IIT Madras provides a model for integrated innovation, replicating its success nationwide is a significant challenge.

Why Commercialization Struggles: The 'Valley of Death' and Low Private Investment

Key challenges hinder the successful commercialization of innovation. India performs well in early research (Technology Readiness Levels 1-3) but struggles significantly to turn these findings into market-ready products (TRLs 7-9). This "valley of death" is driven by weak ties between academia and industry, limited technology transfer mechanisms, and a cautious private sector that often prefers to license existing technologies rather than invest in original, high-risk R&D. Red tape, slow approvals, and rigid procurement rules further delay and deter research progress. Large family businesses and pressure for short-term profits discourage long-term R&D investments, contributing to a weak innovation culture. The low private sector R&D expenditure, often stemming from a preference for business models based on low labor costs over fundamental technological innovation, represents the main problem rather than just a funding shortage. This systemic weakness creates a gap between stated goals and actual spending and use of research funds, undermining the ecosystem it aims to build.

Path Forward: Boosting Applied Research and Commercialization

Government efforts, including the ₹1 lakh crore Research, Development, and Innovation (RDI) Scheme launched in November 2025 and the establishment of the Anusandhan National Research Foundation (ANRF), aim to foster private sector-led innovation and speed up commercialization. These initiatives seek to reduce technological and financial risks for companies, encouraging greater private R&D investment. However, their success depends on overcoming deep-rooted structural issues. India's innovation path ahead will require not only increased R&D budgets but also reforms to systems that promote risk-taking, streamlined bureaucracy, improved technology transfer, and fostering a culture of practical innovation that turns research into lasting economic growth.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.